The Sugar-Funded Fat-Heart Verdict — Big Sugar Bought the 1967 Conclusion, Exposed in 2016

Summary

On the pages of The New England Journal of Medicine in 1967, three Harvard nutrition scientists — Robert McGandy, D. Mark Hegsted, and department chair Fredrick Stare — published a two-part review, "Dietary Fats, Carbohydrates and Atherosclerotic Vascular Disease," that declared there was "no doubt" the only dietary change needed to prevent coronary heart disease was to cut saturated fat and cholesterol. What the review did not say, and what its readers could not know, was that it had been commissioned, paid for, and editorially steered by the Sugar Research Foundation, the sugar industry's trade body, which had set the review's objective in advance precisely to deflect a rising scientific suspicion that its own product — sucrose — drove heart disease. The promise was an authoritative, disinterested survey of the evidence; the reality was a literature review with a sponsor who had already approved the answer.

The mechanism was exposed nearly half a century later. In September 2016, UCSF researchers Cristin Kearns, Laura Schmidt, and Stanton Glantz published an analysis in JAMA Internal Medicine of more than 340 industry documents totaling 1,582 pages. The papers showed that the Sugar Research Foundation paid the authors roughly $6,500 — about $48,000–$50,000 in 2016 dollars — under the codename "Project 226," supplied the articles to be reviewed, defined the objective, and read drafts. The foundation's vice-president for research, John Hickson, told the authors his interest lay in answering claims "that carbohydrates in the form of sucrose make an inordinate contribution," and wrote that he would be "disappointed if this aspect is drowned out." On 2 November 1966 Hickson pronounced a draft "quite what we had in mind." None of this appeared in the published paper.

The cost was not a single bad study but a generation of misdirected emphasis. The NEJM at the time required no conflict-of-interest disclosure, so the review entered the literature as neutral science and helped anchor a five-decade national focus on dietary fat while sugar's cardiometabolic role went comparatively under-investigated. Hegsted later became a key architect of U.S. federal dietary guidance, including the 1977 Dietary Goals for the United States. The findings were never formally retracted — the review remains in the record — but its evidentiary standing collapsed once the funding and editorial control were documented.

This dossier records "Overturned" entry TH-005 as the archetype of the captured review: not a forged dataset but a curated one, in which the harm was the silent purchase of a conclusion and the institutional norm — no disclosure required — that let the purchase pass as scholarship for forty-nine years.

Timeline

1954

The commercial premise

A sugar-trade executive notes that getting Americans onto a low-fat diet would raise per-capita sucrose consumption by "more than a third" — sugar's interest in promoting fat as the villain is established years early.

1962–1965

Sucrose under suspicion

Researchers including John Yudkin in the UK publish evidence implicating sugar in coronary heart disease, generating media attention the industry views as a threat.

1965

The Sugar Research Foundation acts

The SRF launches its first coronary-heart-disease research program; its inaugural project is a commissioned literature review.

Jul 1965

Project 226 commissioned

SRF research director John Hickson engages Harvard's Hegsted and colleagues to write a review answering the sucrose claims, paying roughly $6,500 (~$48,000 in 2016 dollars).

1965–1966

Industry sets the frame

Hickson defines the objective, supplies articles to include, and signals he expects the sucrose critique "drowned out"; Hegsted complains that "every time the Iowa group publishes a paper we have to rework a section in rebuttal."

2 Nov 1966

Sponsor signs off

Hickson reviews a late draft and confirms it is "quite what we had in mind" — the sponsor approving its own commissioned conclusion.

1967

Publication in NEJM

The two-part review appears in The New England Journal of Medicine, concluding the only needed change is cutting fat and cholesterol; the SRF's funding and role go unmentioned.

1977

Policy entrenchment

Hegsted helps shape the U.S. Senate's Dietary Goals for the United States, cementing fat-centric guidance into federal nutrition policy.

1984

NEJM adopts disclosure

The journal begins requiring conflict-of-interest disclosure — a reform that would have flagged Project 226 had it existed in 1967.

2007–2015

The archive surfaces

Dentist-turned-researcher Cristin Kearns uncovers and assembles sugar-industry internal documents from library archives, building the evidentiary base.

12 Sep 2016

The exposé

Kearns, Schmidt and Glantz publish in JAMA Internal Medicine (DOI 10.1001/jamainternmed.2016.5394), documenting the payment, codename, and editorial control; global coverage follows.

A Conclusion Purchased in Advance

The 1967 review's defect was not in its arithmetic but in its premise. A literature review is, in principle, a disinterested map of a field; its authority rests on the assumption that the cartographer has no stake in where the roads lead. Project 226 inverted that assumption from the start. The Sugar Research Foundation did not fund open inquiry and accept the result; it defined the question — answer the sucrose critics — selected which studies entered the survey, and retained the right to read and approve drafts before publication. Hickson's correspondence makes the intent explicit: his "particular interest" was the claim that sucrose made "an inordinate contribution" to metabolic disease, and he warned against letting that point be "drowned out." When a sponsor sets the objective, curates the inputs, and signs off on the output as "quite what we had in mind," the review is no longer a finding; it is an advertisement with footnotes. The structural lesson is that bias need not falsify a single number — it can operate entirely through what is chosen, framed, and emphasized.

The Norm That Made It Invisible

What allowed the purchase to pass as scholarship was an institutional vacuum, not an individual lie. In 1967 The New England Journal of Medicine required no disclosure of funding sources or conflicts of interest; the review's authors disclosed their other industry and government grants in the conventions of the day, but the SRF's specific sponsorship and participation simply had no mandatory channel through which to appear. The journal would not adopt conflict-of-interest disclosure until 1984. For seventeen years the field's flagship vehicle carried commissioned reviews with no requirement to name who paid for them — and for forty-nine years this particular review sat in the record stripped of the one fact that would have let any reader weigh it correctly. The reversal, when it came, exposed an entire era's blind spot: the assumption that prestigious authorship and a prestigious masthead were sufficient guarantors of independence.

Excavation, Not Refutation

The undoing arrived through archaeology rather than experiment. Cristin Kearns, a dentist who grew suspicious of the sugar industry's posture, spent years locating and assembling internal trade-association documents scattered through library collections. With Laura Schmidt and Stanton Glantz at UCSF, she reconstructed the paper trail of Project 226 — the letters, the payment of roughly $6,500, the codename, the drafts, Hickson's approval — and published it in JAMA Internal Medicine on 12 September 2016. The exposé did not need to re-litigate whether fat or sugar causes heart disease; it needed only to show that a foundational review of that question had been bought and steered without disclosure. Marion Nestle of NYU called the documents a "smoking gun" and observed that "science is not supposed to work this way." The verdict was thus not that the review's chemistry was wrong but that its provenance was corrupt — a different and, for the literature, more corrosive kind of failure.

Contributing Factors

01

Sponsor-defined objective

The Sugar Research Foundation did not commission an open question; it commissioned an answer, instructing the authors to rebut claims that sucrose drove heart disease. When the funder sets the conclusion the review is meant to reach, the survey's apparent neutrality is fictional from the first page, regardless of how the individual citations are handled.

02

Editorial control by the funder

Beyond paying, the SRF supplied the articles to be reviewed, read drafts, and approved the final framing ("quite what we had in mind"). Control over inputs and sign-off over outputs let the sponsor shape the conclusion without authoring a single sentence itself — capture exercised through curation rather than fabrication.

03

Absence of disclosure norms

NEJM required no conflict-of-interest statement in 1967 and would not until 1984. The harm was enabled less by the authors than by an institutional vacuum: there was no mandatory mechanism through which the funding and the funder's participation could surface, so they did not.

04

Prestige as a credibility shortcut

Harvard authorship and the NEJM masthead substituted for scrutiny of independence. Readers and policymakers treated the source's reputation as a proxy for disinterest, allowing a commissioned document to enter the canon as settled science and to anchor downstream guidance.

05

Latency between influence and exposure

Because the documents lived in private archives and no disclosure compelled their release, the conflict stayed buried for forty-nine years. By the time it was excavated, the review had already done its work on emphasis and policy — the damage was historical, not preventable by the eventual correction.

Aftermath

The material consequence is contested but real: for roughly five decades, American nutrition emphasis and federal guidance leaned toward dietary fat as the primary cardiovascular villain while sugar's cardiometabolic role drew comparatively less scrutiny, a tilt the 1967 review helped legitimize at the field's most prestigious address. The durable ripple is institutional. The 2016 exposé became a flagship case in the literature on industry-funded research, cited alongside the tobacco playbook as evidence that trade groups manufacture doubt and emphasis through ostensibly independent science; it strengthened arguments for mandatory funding disclosure, sponsor-independence statements, and the registration of review objectives. The Sugar Association responded that the study cast "questionable" judgments on decades-old events by modern standards and noted disclosure norms differed then — a defense that concedes the facts while disputing the frame. What remains is a review never formally retracted yet permanently discredited as a source: it sits in the record as a cautionary specimen rather than a citation. "Overturned" files this as TH-005 because it is the cleanest example of the family's quiet variant — not a fraudulent dataset but a purchased and steered survey, debunked not by re-running the science but by reading the invoices.

Lessons

Audit who set the question, not just who ran the numbers: a review can be entirely accurate in its citations and still be captured if the sponsor defined the objective and curated the inputs — interrogate the brief, not only the data.
Treat absence of a disclosure as data, not as innocence: when a foundational claim predates conflict-of-interest norms, assume the funding is unknown until proven otherwise, and weight the source accordingly.
Do not let prestige stand in for independence: an eminent author and a flagship journal raise the cost of scrutiny but do not lower the need for it; reputation is not a substitute for a money trail.
Require sponsors to declare objectives in advance, and make review protocols and funding public — capture exercised through framing and selection is invisible unless the brief and the bankroll are on the record.
Protect and fund the archivists: this reversal came from one researcher reading decades-old industry memos in library basements, so resource the document excavation that surfaces conflicts the disclosure system never captured.